Permanent neonatal diabetes mellitus due to a C96Y heterozygous mutation in the insulin gene. A case report

• Published in: Journal of the Pancreas Vol. 9; no. 6; pp. 715 - 718
• Main Authors: Ahamed, Anish, Unnikrishnan, Ambika Gopalakrishnan, Pendsey, Sanket Sharad, Nampoothiri, Sheela, Bhavani, Nisha, Praveen, Valliyaparambil Pavithran, Kumar, Harish, Jayakumar, Rohinivilasam Vasukutty, Nair, Vasantha, Ellard, Sian, Edghill, Emma L
• Format: Journal Article
• Language: English
• Published: Italy 03-11-2008
• Subjects: Amino Acid Substitution; Diabetes Mellitus - congenital; Diabetes Mellitus - drug therapy; Diabetes Mellitus - genetics; Diagnosis, Differential; Heterozygote; Humans; Hyperglycemia - etiology; Infant; Insulin - genetics; Insulin - therapeutic use; Male
• ISSN: 1590-8577

Neonatal diabetes is a rare disorder with an incidence of 1 in 215,000-500,000 live births with 50% of them having permanent neonatal diabetes mellitus.
We present a case of permanent neonatal diabetes mellitus due to a C96Y (c.287G>A; p.Cys96Tyr) heterozygous mutation in the insulin (INS) gene. Both the patient and his father (who had childhood-onset insulin-requiring diabetes) were found to be carriers of a heterozygous missense mutation C96Y in exon 3 of the INS gene. It has been hypothesized that these mutations disrupt the folding of the proinsulin molecule and result in a misfolded protein or retention of the protein in the endoplasmic reticulum, resulting in endoplasmic reticulum stress and beta cell apoptosis. Subjects with this form of diabetes will need lifelong insulin therapy.
Insulin gene mutations appear to be an important cause of neonatal diabetes worldwide. This is the first report of a case from the Indian subcontinent. It is important to carry out genetic tests for mutations linked to pancreatic beta cell dysfunction in all patients with persistent neonatal diabetes mellitus in order to decide on therapy.